Bridgeway Capital Management’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.7M Buy
2,473,468
+40,950
+2% +$457K 0.4% 56
2026
Q1
$26.3M Sell
2,432,518
-247,036
-9% -$2.11M 0.53% 22
2025
Q4
$16.4M Buy
+2,679,554
New +$16M 0.34% 73
2022
Q4
Sell
-899,000
Closed -$10.5M 1442
2022
Q3
$10.5M Hold
899,000
0.28% 69
2022
Q2
$14.2M Hold
899,000
0.32% 53
2022
Q1
$13.9M Hold
899,000
0.27% 90
2021
Q4
$7.6M Hold
899,000
0.14% 241
2021
Q3
$8.09M Buy
899,000
+70,000
+8% +$567K 0.15% 200
2021
Q2
$8.24M Hold
829,000
0.15% 189
2021
Q1
$5.91M Hold
829,000
0.11% 249
2020
Q4
$4.36M Hold
829,000
0.09% 281
2020
Q3
$2.36M Hold
829,000
0.05% 367
2020
Q2
$2.88M Buy
829,000
+615,000
+287% +$2.12M 0.06% 307
2020
Q1
$503K Buy
+214,000
New +$1.38M 0.01% 759

Other funds holding PTEN

Bridgeway Capital Management's PTEN Position: Q2 2026 in Review

Bridgeway Capital Management increased its Patterson-UTI (PTEN) stake by 1.7% in Q2 2026, buying an estimated $457K and bringing the position to 2,473,468 shares worth $22.7M. The position accounts for 0.4% of the portfolio, ranked #56.

Bridgeway Capital Management first reported a position in PTEN in Q1 2020 and has held it in 14 quarters since. The position peaked at $26.3M in Q1 2026. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Bridgeway Capital Management held 2,473,468 shares of Patterson-UTI worth $22.7M as of Q2 2026.
  • Bridgeway Capital Management bought 40,950 Patterson-UTI shares in Q2 2026, an estimated $457K.
  • Patterson-UTI made up 0.4% of Bridgeway Capital Management's portfolio in Q2 2026, its #56 holding.
  • Bridgeway Capital Management first reported a position in Patterson-UTI in Q1 2020 and has held it in 14 quarters since.
  • Bridgeway Capital Management's Patterson-UTI position peaked at $26.3M in Q1 2026.
  • 438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.